Table 4 Overall Response according to PERCIST Criteria
From: 18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Response type | Status | SUV percentage Change (range) | X2 | P | ||
|---|---|---|---|---|---|---|
Overall No. 79 (100%) | Synchronous 35 (44.3%) | Metachronous 44 (55.7%) | ||||
CMR | 17 (21.5%) | 3 (8.5%) | 14 (31.8%) | – 100% | 10.5 | 0.015* |
PMR | 42 (53.1%) | 24 (68.6%) | 18 (40.9%) | – 38:17% | ||
PMD | 16 (20.3%) | 7 (20%) | 9 (20.5%) | 33:56% | ||
SMD | 4 (5.1%) | 1 (2.9%) | 3 (6.8%) | – 8:21% | ||